https://www.news-medical.net/news/20201211/Favipiravir-does-not-attenuate-the-progression-of-COVID-19.aspx
Scientists have conducted an observational study to evaluate the efficacy of an anti-influenza medicine favipiravir in treating hospitalized COVID-19 patients.
favipiravirattenuateprogressioncovid
https://www.indiamart.com/proddetail/400mg-favipiravir-tablets-drug-license-required-24202094433.html?pos=5&DualProdscaps
Get FaviBluz 400mg Favipiravir Tablets, Drug License Required at best price in Chennai, Tamil Nadu by Sarva Enterprises and more wholesalers | ID: 24202094433
favipiravirtabletsdruglicenserequired
https://www.prnewswire.com/ae/news-releases/rdif-and-chemrar-announce-first-interim-results-of-clinical-trials-of-favipiravir-drug-s-effectiveness-in-coronavirus-therapy-814057186.html
/PRNewswire/ -- The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and the ChemRar Group today announce the positive first interim...
clinical trialsrdifannouncefirstinterim
https://pubmed.ncbi.nlm.nih.gov/36591698/
Pandemic new severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus has increased throughout the world. There is no effective treatment against this...
main proteaseidentificationpotentcovidinhibitors